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Draft Genome Sequence for Pseudomonas aeruginosa Strain PAO579,
a Mucoid Derivative of PAO381
T. Ryan Withers,a Shannon L. Johnson,d and Hongwei D. Yua,b,c
Departments of Biochemistry and Microbiologya and Pediatrics,b Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia, USA; Progenesis
Technologies, LLC, Huntington, West Virginia, USAc; and Genome Science Group (B6), Los Alamos National Laboratory, Los Alamos, New Mexico, USAd
Pseudomonas aeruginosa is an opportunistic pathogen that establishes a chronic lung infection in individuals afflicted with cys-
tic fibrosis. Here, we announce the draft genome of P. aeruginosa strain PAO579, an alginate-overproducing derivative of strain
PAO381.
Pseudomonas aeruginosa is a ubiquitous, opportunistic patho-gen and the leading cause of mortality with individuals af-
flictedwith cystic fibrosis (CF).P. aeruginosauses the overproduc-
tion of an exopolysaccharide, called alginate, to form mucoid
biofilms. Biofilm formation is responsible for the development of
chronic infections, as well as increased resistance to antibiotic
treatment (2), and reduced phagocytosis by macrophages (4). P.
aeruginosa strain PAO579 was first isolated as a mucoid, alginate-
overproducing variant of PAO381, a derivative of the nonmucoid
reference strain PAO1 (3, 5). Both PAO579 and PAO381 have a
wild-type mucA gene (mucA), and both strains are leucine auxot-
rophic (leu38) and streptomycin resistant (strA2).
Genomic DNA from P. aeruginosa strain PAO579 was isolated
using phenol-chloroform extraction and ethanol precipitation;
paired-end sequencing libraries were generated using vendor pro-
tocols (Illumina, San Diego, CA); and genome sequencing was
performed on an Illumina GAIIX with 60-bp-length sequencing
generating 54,496,482 raw reads covering a total of 3,269,788,920
bp. Data were generated and assembled using Illumina Pipeline
version SCS 2.8.0 paired with OLB 1.8.0 and aligned with the P.
aeruginosa strain PAO1 reference genome (GenBank accession
no. NC_2516.2) using NovoAlign version 2.07.10. All specifics
regarding aligner algorithms can be obtained from Novocraft,
Selangor, Malaysia. The total number of base pairs aligned with
the reference genome is 2,077,041,840 bp, representing an average
of 340 per target base pair aligned. The number of bases satu-
rated at or above 8 is 6,016,396 (96.04%), and the number of
bases saturated below 8 is 248,008 (3.96%). The total number of
reference bases covered is 6,036,589 (96.36%) with the total num-
ber of bases missed being 227,815 (3.64%). There are a total of 16
contigs (ALOF01000001 to ALOF01000016). Further analysis of
the genome was performed using Samtools version 0.1.16a for the
generation of pileup after sorting and removing supplicate reads
and then analysis pipeline software developed by Cofactor
Genomics (St. Louis, MO). The genome was annotated and pre-
pared for submission using the NCBI Prokaryotic Genomes Au-
tomatic Annotation Pipeline (PGAAP; http://www.ncbi.nlm.nih
.gov.genomes/static/Pipeline.html) server at NCBI.
Based upon this analysis, a total of 31 homozygous single nu-
cleotide polymorphisms (SNPs), or point mutations, were called
with a high confidence between the sequenced reads and the
PAO1 reference genome and were tabulated for each genomic
position, as well as the total coverage of bases observed at that
location. Of particular interest is the substitution of thymine for
adenine at genome position 4980548 in the DegS-like MucA pro-
tease gene, algW (PA4446). This alteration results in a change in
the primary structure of AlgW, more specifically a substitution of
isoleucine for phenylalanine at amino acid position 239. This pre-
dicted substitution is thought to affect the proteolytic activity of
AlgW (1). Also of note, we observed mutations in leuA (PA3792),
the 2-isopropylmalate synthase gene, and rpsL (PA4268), the 30S
ribosomal protein S12 gene. These mutations are contiguously
part of the PAO381 lineage and are responsible for leucine auxot-
rophy and streptomycin resistance, respectively.
Nucleotide sequence accession number. The draft genome
sequence of P. aeruginosa strain PAO579 has been deposited in
GenBank under accession number ALOF00000000.
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